Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ATAI
ATAI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ATAI News
Helus Pharma Advances New Drug for Anxiety Treatment
7h ago
Newsfilter
Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results
8h ago
PRnewswire
AtaiBeckley Explores Strategic Options for BPL-003
2d ago
seekingalpha
Atai Beckley Reports Q4 Loss with $1.06M Revenue
3d ago
seekingalpha
AtaiBeckley Reports Q4 and Full Year 2025 Financial Results
3d ago
NASDAQ.COM
Helus Pharma's HLP004 Phase 2 Study Results Disappoint
4d ago
Benzinga
Helus Pharma Advances Mental Health Drug Development
Feb 27 2026
Newsfilter
Helus Pharma Advances Psychedelic Drug Clinical Trials
Feb 27 2026
PRnewswire
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
AtaiBeckley Reports Positive EMP-01 Trial Results for Social Anxiety Disorder
Feb 26 2026
Benzinga
ATAI Reports Positive Results for EMP 01 in Social Anxiety Disorder Study
Feb 26 2026
NASDAQ.COM
AtaiBeckley Appoints New CFO Michael Faerm
Feb 19 2026
seekingalpha
AtaiBeckley Provides 2026 Outlook with Accelerated Drug Development Plans
Jan 08 2026
Globenewswire
GH Research Secures FDA Clearance for GH001 Clinical Trial
Jan 05 2026
Benzinga
Organigram Expands Investment in Phylos to $10 Million for Cannabis Genetics
Jan 04 2026
Yahoo Finance
AtaiBeckley Completes Redomiciliation from Netherlands to U.S.
Dec 31 2025
Globenewswire
Show More News
